MX2009009197A - Mejora de respuesta a tension celular. - Google Patents

Mejora de respuesta a tension celular.

Info

Publication number
MX2009009197A
MX2009009197A MX2009009197A MX2009009197A MX2009009197A MX 2009009197 A MX2009009197 A MX 2009009197A MX 2009009197 A MX2009009197 A MX 2009009197A MX 2009009197 A MX2009009197 A MX 2009009197A MX 2009009197 A MX2009009197 A MX 2009009197A
Authority
MX
Mexico
Prior art keywords
amelioration
stress response
cellular stress
cellular
chemotherapy
Prior art date
Application number
MX2009009197A
Other languages
English (en)
Inventor
William Mallet
Charles Tindell
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genentech Inc filed Critical Genentech Inc
Publication of MX2009009197A publication Critical patent/MX2009009197A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7088—Compounds having three or more nucleosides or nucleotides
    • A61K31/711—Natural deoxyribonucleic acids, i.e. containing only 2'-deoxyriboses attached to adenine, guanine, cytosine or thymine and having 3'-5' phosphodiester links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5011—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing antineoplastic activity

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Toxicology (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Zoology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La presente invención se dirige a composiciones y métodos útiles para tratar cáncer y para mejorar respuesta a tensión celular activada por quimioterapia.
MX2009009197A 2007-03-02 2008-03-03 Mejora de respuesta a tension celular. MX2009009197A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US89280607P 2007-03-02 2007-03-02
PCT/US2008/055714 WO2008109560A2 (en) 2007-03-02 2008-03-03 Amelioration of cellular stress response

Publications (1)

Publication Number Publication Date
MX2009009197A true MX2009009197A (es) 2009-09-04

Family

ID=39532129

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2009009197A MX2009009197A (es) 2007-03-02 2008-03-03 Mejora de respuesta a tension celular.

Country Status (8)

Country Link
EP (1) EP2118133A2 (es)
JP (1) JP2010521425A (es)
CN (1) CN101790539A (es)
AU (1) AU2008222926A1 (es)
CA (1) CA2678555A1 (es)
IL (1) IL200483A0 (es)
MX (1) MX2009009197A (es)
WO (1) WO2008109560A2 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2461813A4 (en) * 2009-08-05 2014-02-19 Univ Wake Forest Health Sciences COMPOSITIONS AND METHODS FOR INDUCING APOPTOSIS IN PROSTATE CANCER CELLS

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6790631B1 (en) * 1999-10-05 2004-09-14 Agensys, Inc. G protein-coupled receptor up-regulated in prostate cancer and uses thereof

Also Published As

Publication number Publication date
CN101790539A (zh) 2010-07-28
IL200483A0 (en) 2010-04-29
WO2008109560A2 (en) 2008-09-12
EP2118133A2 (en) 2009-11-18
AU2008222926A1 (en) 2008-09-12
WO2008109560A3 (en) 2008-12-11
JP2010521425A (ja) 2010-06-24
CA2678555A1 (en) 2008-09-12

Similar Documents

Publication Publication Date Title
PH12019502809A1 (en) Substituted tricyclic compounds as fgfr inhibitors
EA201201000A1 (ru) Способы лечения колоректального рака
MX2010009765A (es) Moleculas pequeñas que contienen boro como agentes anti-inflamatorios.
MY160399A (en) Compounds, compositions, and methods for preventing metastasis of cancer cells
EP2185197A4 (en) NOVEL COMPOSITIONS OF A SOLUTION CONTAINING A CELLULAR FACTOR
MY192633A (en) 1,2,5-oxadiazoles as inhibitors of indoleamine 2,3-dioxygenase
MX2009001309A (es) Compuestos de heteroarilo utiles como inhibidores de enzimas de activacion e1.
MX2011014019A (es) Derivados de diazahomoadamantano y sus metodos de uso.
IN2012DN03883A (es)
EA201291194A1 (ru) Индолы
IN2014KN02601A (es)
EP2170337A4 (en) NEW TRIAZOLOPYRIDAZINE
GEP20156266B (en) Spiroheterocyclic n-oxypiperidines as pesticides
WO2010111406A3 (en) Purine derivatives useful as anti - cancer agents
WO2011083090A3 (en) Methods for treating breast cancer
MX2012010434A (es) Compuestos y composiciones novedosas para atacar a las celulas madre del cancer.
HK1133642A1 (en) Azaadamantane ester and carbamate derivatives and methods of use thereof
UA106889C2 (uk) Похідні n1-ацил-5-фторпіримідинону
MX2009010176A (es) Derivados de aza-adamantano 4-substituidos y metodos de uso de los mismos.
MX350392B (es) Aceite de sandalo y sus usos.
HK1131609A1 (en) Acetamide and carboxamide derivatives of azaadamantane and methods of use thereof
WO2009126335A3 (en) Ant2 inhibitor compounds and methods of use thereof
MX2009009197A (es) Mejora de respuesta a tension celular.
MX2015012523A (es) Metodos para elaborar composiciones antineoplasicas.
PH12016502133A1 (en) Substituted tricycle compounds as fgfr inhibitors

Legal Events

Date Code Title Description
FA Abandonment or withdrawal